Bioventix PLC (LON:BVXP – Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 1,595.09 and traded as high as GBX 1,750. Bioventix shares last traded at GBX 1,620, with a volume of 3,393 shares.
Bioventix Trading Down 2.8%
The company has a market capitalization of £82.29 million, a PE ratio of 11.21 and a beta of 0.56. The firm has a fifty day moving average of GBX 1,595.09 and a two-hundred day moving average of GBX 1,623.28.
Insiders Place Their Bets
In related news, insider Bruce Hiscock purchased 534 shares of the business’s stock in a transaction that occurred on Wednesday, June 24th. The shares were acquired at an average price of GBX 1,799 per share, for a total transaction of £9,606.66. 6.23% of the stock is currently owned by company insiders.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
See Also
- Five stocks we like better than Bioventix
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
